Replies to post #185291 on Enzolytics Inc (ENZC)

[I-Glow]

Those are very old and both have been assigned to The Zhabilov Trust.

The PCT is meaningless as the company still has to file a patent application in each country.

What is amazing is that ENZC investors don't understand that a drug patent is worthless because until the drug passes FDA approved clinical trials.

All pharmaceutical companies apply to the FDA to start clinical trials - if they believe a drug is going to pass the clinical trials the US is the first place to go.

Here is an example, GW Pharmaceuticals spend over $100M to do clinical trials on Epidiolex. In the first year GW Pharmaceuticals had revenue of $300M on Epidiolex only.

ENZC doesn't have the capital to do any FDA approved clinical trials.

The ENZC shareholders have been duped by the insiders.

IG

[I-Glow]

Those are very old and both have been assigned to The Zhabilov Trust.

The PCT is meaningless as the company still has to file a patent application in each country.

What is amazing is that ENZC investors don't understand that a drug patent is worthless because until the drug passes FDA approved clinical trials.

All pharmaceutical companies apply to the FDA to start clinical trials - if they believe a drug is going to pass the clinical trials the US is the first place to go.

Here is an example, GW Pharmaceuticals spend over $100M to do clinical trials on Epidiolex. In the first year GW Pharmaceuticals had revenue of $300M on Epidiolex only.

ENZC doesn't have the capital to do any FDA approved clinical trials.

The ENZC shareholders have been duped by the insiders.

IG

[Catpole]

Thank you! Progress continues to be made.